Your browser doesn't support javascript.
loading
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.
van Zyl-Smit, Richard N; Chapman, Kenneth R; Kerstjens, Huib A M; Gessner, Christian; Sagara, Hironori; Tanase, Ana-Maria; Hosoe, Motoi; Pethe, Abhijit; Lawrence, David; Tillmann, Hanns-Christian; D'Andrea, Peter.
Afiliação
  • van Zyl-Smit RN; Division of Pulmonology and UCT Lung Institute, University of Cape Town, Cape Town, South Africa.
  • Chapman KR; Division of Respiratory Medicine, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Kerstjens HAM; Department of Pulmonology, University of Groningen, University Medical Center Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
  • Gessner C; Universitätsklinikum Leipzig, Germany POIS Leipzig GbR, Leipzig, Germany.
  • Sagara H; Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Tanase AM; Novartis Pharma AG, Basel, Switzerland.
  • Hosoe M; Novartis Pharma AG, Basel, Switzerland.
  • Pethe A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Lawrence D; Novartis Pharma AG, Basel, Switzerland.
  • Tillmann HC; Novartis Institutes for BioMedical Research, Translational Medicine, Basel, Switzerland.
  • D'Andrea P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
J Asthma Allergy ; 16: 123-134, 2023.
Article em En | MEDLINE | ID: mdl-36714049

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article